Hinge Health affiliate notifies sale of Class A shares

Hinge Health, Inc. affiliate submitted a notice reporting proposed sales of Class A common shares.

Rhea-AI Filing Summary

Hinge Health, Inc. affiliate submitted a notice reporting proposed sales of Class A common shares. The filings list multiple transactions in June 2026 by Insight Venture Partners (Cayman) X, L.P., showing individual sales and dollar amounts on specific dates. The report also references Series B preferred stock tied to a pre-IPO conversion.

Insights

Securities Attorney

Notice documents proposed secondary sales by an affiliate; transactions are resale‑type disclosures.

The filing lists multiple Class A share dispositions by Insight Venture Partners (Cayman) X, L.P., with per‑trade share counts and gross proceeds reported for June 2026. These are notices of proposed sales under resale rules rather than issuer primary offerings.

The cash‑flow treatment is governed by the selling holder; timing and execution details are tied to the individual sale dates listed in the notice. Subsequent regulatory or broker reports will show actual settlement details.

Key Figures

Sale - 06/16/2026: 5,195 shares / $365,518.12 Sale - 06/22/2026: 17,776 shares / $1,261,280.08 Sale - 06/23/2026: 8,910 shares / $625,611.20 +3 more

6 metrics

Sale - 06/16/2026 5,195 shares / $365,518.12 Insight Venture Partners (Cayman) X, L.P. sale entry

Sale - 06/22/2026 17,776 shares / $1,261,280.08 Insight Venture Partners (Cayman) X, L.P. sale entry

Sale - 06/23/2026 8,910 shares / $625,611.20 Insight Venture Partners (Cayman) X, L.P. sale entry

Sale - 06/24/2026 42,240 shares / $3,008,045.57 Insight Venture Partners (Cayman) X, L.P. sale entry

Sale - 06/25/2026 42,062 shares / $3,021,040.06 Insight Venture Partners (Cayman) X, L.P. sale entry

Sale - 06/29/2026 (largest listed) 116,183 shares / $9,623,856.15 Insight Venture Partners (Cayman) X, L.P. sale entry

Key Terms

Form 144, Class A, Series B Preferred, Stock Conversion before IPO

4 terms

Form 144 regulatory

"The filing lists multiple proposed sales dated June 2026 under the heading 144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Class A financial

"Entries repeatedly label the sold securities as Class A in the selling holder rows"

Class A denotes a specific group of a company’s shares that carry a particular set of rights—most commonly different voting power or dividend priority compared with other share classes. Think of it like different seats on a bus where some seats let you steer and others only ride: knowing whether a share is Class A tells investors how much influence they have over company decisions and how returns might be distributed, which affects control and value.

Series B Preferred financial

"Series B Preffered | 07/03/2018 | Stock Conversion before IPO"

Series B preferred is a class of ownership created during a later private funding round that gives investors special rights ahead of ordinary shareholders. Think of it like a priority ticket at a crowded exit: holders get paid or reimbursed before common shareholders if the company is sold or winds down, often receive fixed payments or protection against value loss, and typically have options to convert into regular shares; those features affect potential returns and control for investors.

Stock Conversion before IPO corporate

"Series B Preffered | 07/03/2018 | Stock Conversion before IPO"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the HNGE Form 144 notice disclose?

It discloses proposed sales of Class A shares by an affiliate. The filing lists multiple June 2026 transactions by Insight Venture Partners (Cayman) X, L.P., each with share counts and gross dollar amounts.

Who is the selling holder in the HNGE filing?

The selling holder is Insight Venture Partners (Cayman) X, L.P. The notice lists that entity's address and multiple June 2026 sale entries with dates, share quantities, and dollar proceeds.

How many shares and proceeds are shown for the largest trade?

The largest listed trade is 116,183 shares for $9,623,856.15. That sale is dated 06/29/2026 and is reported in the sequence of June 2026 transactions.

Does the filing register new securities or an issuer offering?

No. The notice reports resale transactions by a selling holder, not a primary issuer offering. It also references Series B preferred stock conversion before IPO as context in the filing.

Are the sales primary proceeds to the company?

Proceeds appear tied to the selling holder's dispositions. The filing lists gross proceeds per trade and does not state that proceeds flow to the issuer in the provided excerpt.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/07/2026 - 04:37 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001710835
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Hinge Health, Inc.
SEC File Number	001-42657
Address of Issuer	455 MARKET STREET 7TH FLOOR SAN FRANCISCO CALIFORNIA 94105
Phone	415-689-8429
Name of Person for Whose Account the Securities are To Be Sold	Insight Venture Partners (Delaware) X, L.P.
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A	Raymond James & Associates 880 Carillon Parkway St. Petersburg FL 33716	116183	10456470.00	54655926	07/07/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Series B Preffered	07/03/2018	Stock Conversion before IPO	Hinge Health, Inc.			3678282	07/03/2018	Wired to portfolio company

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Insight Venture Partners (Cayman) X, L.P. 1114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/16/2026	5195	365518.12
Insight Venture Partners (Cayman) X, L.P. 1114 Avenue of the Americas 36th Floor New York, NY 10036	Class A	06/22/2026	17776	1261280.08
Insight Venture Partners (Cayman) X, L.P. 1114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/23/2026	8910	625611.20
Insight Venture Partners (Cayman) X, L.P 114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/24/2026	42240	3008045.57
nsight Venture Partners (Cayman) X, L.P 114 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/25/2026	42062	3021040.06
nsight Venture Partners (Cayman) X, L.P 14 Avenue of the Americas 36th Floor New York NY 10036	Class A	06/29/2026	116183	9623856.15

144: Remarks and Signature

Remarks
Date of Notice	07/07/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/20/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Rashida Mitchell, as duly authorized representative of Raymond James & Associates, Inc., as attorney-in-fact for Insight Venture Partners (Deleware) X
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)